[1] |
徐宝丽,管甲亮,术超,等. 新型冠状病毒COVID-19相关研究进展[J]. 中华医院感染学杂志,2020,30(6):839-844.
|
[2] |
RICHMAN D D,WHITLEY R J,HAYDEN F G.Clinical virology[M]. 4th. Washington:ASM Press,2016.
|
[3] |
LI Q,GUAN X,WU P,et al.Early transmission dynamics in Wuhan,China,of novel coronavirus-infected pneumonia[J]. N Engl J Med,2020,382(13):1199-1207.
|
[4] |
CHAN J F,YUAN S,KOK K H,et al.A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster[J]. Lancet,2020,395(10223):514-523.
|
[5] |
国家卫生健康委办公厅. 新型冠状病毒肺炎诊疗方案(试行第七版)[EB/OL].(2020-03-03)[2020-03-10]. .
|
[6] |
ZHANG C,WANG M. Origin time and epidemic dynamics of the 2019 novel coronavirus[EB/OL].(2020-01-25) [2020-02-29]. .
|
[7] |
ZHU N,ZHANG D,WANG W,et al.A novel coronavirus from patients with pneumonia in China,2019[J]. N Engl J Med,2020,382(8) :727-733.
|
[8] |
HUANG C,WANG Y,LI X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J]. Lancet,2020,395(10223):497-506.
|
[9] |
DE WIT E,VAN DOREMALEN N,FALZARANO D,et al.SARS and MERS:recent insights into emerging coronaviruses[J]. Nat Rev Microbiol,2016,14(8):523-534.
|
[10] |
梁继仁,韦松华,钱秀芳,等. 14例新型冠状病毒肺炎病例流行病学和临床特征[J]. 中国感染控制杂志,2020,19(3):245-249.
|
[11] |
范久波,孙莉,何家富,等. SAA联合CRP、血常规检测在新型冠状病毒肺炎中的诊断价值[J]. 检验医学,2020,35(7):640-644.
|
[12] |
房晓伟,梅清,杨田军,等. 2019新型冠状病毒感染的肺炎79例临床特征及治疗分析[J]. 中国药理学通报,2020,36(4):453-459.
|
[13] |
颜宇飞,金一鸣,刘明利,等. NLR在SARS-CoV-2感染中的临床意义探讨[J]. 检验医学,2020,35(7):637-639.
|